INTRODUCTION
This protocol describes a method for the transformation of lymphoblasts by Epstein-Barr Virus (EBV). Cells may be isolated from whole blood or taken from cryopreserved, non-immortalized stocks (please see Cryopreservation of Mammalian Culture Cells: Preparation and Recovery of Samples). The source of infectious EBV is the conditioned medium from marmoset cell line B95-8. 
MATERIALS

Reagents
Equipment:
Tissue culture flask, 25 cm 2 Incubator, 5% CO 2 , preset to 37°C Centrifuge tubes, 15-ml METHOD 1. Combine 10 ml of whole blood with 10 ml of RPMI 1640 growth medium.
2. Separate lymphocytes by layering 4 ml of diluted blood over 3 ml of Histopaque 1077 in 15-ml sterile centrifuge tubes.
3. Centrifuge the Histopaque column at 300g at room temperature for 30 minutes. Discard the clear plasma layer at the top.
4. Collect the opaque lymphocyte layer and pool the cell suspension (~10 ml) into a 50-ml sterile centrifuge tube.
5. Wash twice in 20 ml of RPMI 1640 growth medium. Pellet at 300g at room temperature for 10 minutes after washes.
6. Prepare the cells for immortalization and growth by resuspending the cell pellet derived from 10 ml of blood in 1 ml of EBV-containing supernatant.
7. Place the cell suspension (1 ml) in a 25-cm 2 tissue culture flask and set the flask on end (vertically) in a 5% CO 2 atmosphere at 37°C for 1-3 hours.
8. After incubation, add 3 ml of RPMI 1640 growth medium with 0.2 µg/ml of cyclosporin A to the flask and position the flask horizontally so that the cells flow over the normal growth surface.
Cultures should be observed every few days for increased cell growth. The formation of cell aggregates is an indicator of immortalization.
9. Add fresh RPMI 1640 growth medium (1 ml) with cyclosporin A once a week without removal of spent medium.
Maintain cultures as outlined in Inoculation of Flasks for Mammalian Cell Suspension
Cultures.
